Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy
- 20 August 2020
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 184 (1) , 75-85
Abstract
Introduction Preclinical data demonstrate the potential for exercise training to protect against anthracycline-related cardiotoxicity, but this remains to be shown in humans. Purpose To assess whether exercise training during anthracycline-based chemotherapy for treatment of breast cancer affects resting cardiac function and hemodynamics. Methods In this prospective, non-randomized controlled study, 26 women who participated in aerobic and resistance training 3×/wk during chemotherapy were compared to 11 women receiving usual care. Two-dimensional echocardiography was performed before and 7–14 days after completion of anthracycline-based chemotherapy. Pre- and post-anthracycline cardiac function and hemodynamic variables were compared within each group with paired t-tests; the change was compared between groups using ANCOVA with adjustment for baseline values. Results Left ventricular longitudinal strain, volumes, ejection fraction, E/A ratio, and mass did not change in either group. Hemoglobin, hematocrit, and mean arterial pressure decreased significantly from baseline in both groups (all p < 0.05) with no differences between groups. Cardiac output increased in the usual care group only (+ 0.27 ± 0.24 L/min/m2, p < 0.01), which differed significantly from the exercise group (p = 0.03). Systemic vascular resistance (SVR) decreased in both groups (usual care: − 444, p < 0.01; exercise: − 265, dynes/s/cm5, p = 0.01). However, the reduction in SVR was significantly attenuated in the exercise group (p = 0.03) perhaps due to a compensatory decrease in estimated vessel lumen radius. Conclusion Exercise training during anthracycline chemotherapy treatment had no effect on resting cardiac function but appeared to modify hemodynamic responses. Specifically, exercise training attenuated the drop in SVR in response to chemotherapy-related reductions in hematocrit potentially by increasing vessel lumen radius.Keywords
Funding Information
- American College of Sports Medicine
- BC Cancer Agency
This publication has 21 references indexed in Scilit:
- Evaluation of Cardiotoxicity via Speckle-Tracking Echocardiography in Patients Treated with AnthracyclinesOnkologie, 2013
- Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysisEuropean Journal of Cancer, 2013
- Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trialActa Oncologica, 2013
- Chemotherapy-Associated Cardiotoxicity: How Often Does it Really Occur and How Can it Be Prevented?Heart Failure Clinics, 2011
- Effects of graded heat stress on global left ventricular function and twist mechanics at rest and during exercise in healthy humansExperimental Physiology, 2010
- American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer SurvivorsMedicine & Science in Sports & Exercise, 2010
- High-Intensity Interval Training to Maximize Cardiac Benefits of Exercise Training?Exercise and Sport Sciences Reviews, 2009
- Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac ProblemsClinical Cancer Research, 2008
- Simplified Calculation of Body-Surface AreaNew England Journal of Medicine, 1987
- A questionnaire for the assessment of leisure time physical activitiesJournal of Chronic Diseases, 1978